Periodontal disease and diabetes mellitus: The role of tumor necrosis factor-α in a 2-way relationship

Journal of Periodontology

Volumn 74, Issue 1, 2003, Pages 97-102

  Nishimura, Fusanori ^a   Iwamoto, Yoshihiro ^a   Mineshiba, Junji ^a   Shimizu, Akemi ^a   Soga, Yoshihiko ^a   Murayama, Yoji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus, type 2; Insulin resistance; Obesity; Periodontal diseases etiology; Risk factors; Tumor necrosis factor

Indexed keywords

CYTOKINE; INSULIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; BODY WEIGHT; ENERGY EXPENDITURE; HORMONE ACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROPHAGE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR; WEIGHT REDUCTION;

ADIPOCYTES; CYTOKININS; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; LEPTIN; MACROPHAGES; MONOCYTES; OBESITY; PERIODONTAL DISEASES; PERIODONTITIS; RISK FACTORS; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037261945     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2003.74.1.97     Document Type: Review

References (26)

1. Friedman JM. Obesity in the new millennium. Nature 2000;404:632-634.
2. Nelson RG, Shlossman M, Budding L, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13:836-840.
3. Saito T, Shimazaki Y, Sakamoto M. Obesity and periodontitis. N Engl J Med 1998;339:482-483.
4. Grossi SG, Skrepcinski FB, DeCaro T, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997;68:713-719.
5. Iwamoto Y, Nishimura F, Nakagawa M, et al. The effects of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001;72:774-778.
6. Nishimura F, Murayama Y. Concise review. Periodontal inflammation and insulin resistance - Lessons from obesity. J Dent Res 2001;80:1690-1694.
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415.
8. Dandona P, Weistock R, Thusu K, Abdel-Rahman E, Aljada A, Waden T. Tumor necrosis factor-α in sera of obese patients: Fall with weight loss. J Clin Endocrinol Metab 1998;83:2907-2910.
9. Feingold KR, Doerrler W, Dinarello CA, Fiers W, Grunfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 1992;130:10-16.
10. Gasic S, Tian B, Green A. Tumor necrosis factor-alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J Biol Chem 1999;274:6770-6775.
11. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000;11:212-217.
12. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996;271:665-668.
13. Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-a-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1977;272:971-976.
14. Long SD, Pekala PH. Regulation of GLUT4 mRNA stability by tumor necrosis factor-alpha: Alterations in both protein binding to the 3′ untranslated region and initiation of translation. Biochem Biophys Res Commun 1996;220:949-953.
15. 2 in tumor necrosis factor-α-mediated insulin resistance. J Biol Chem 1999;274:25078-25084.
16. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-2168.
17. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha. Nature 1989;337:661-663.
18. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factor-alpha and -beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-779.
19. Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor-alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000;191:275-286.
20. Cohen DW, Morris AL. Periodontal manifestation of cyclic neutropenia. J Periodontol 1961;32:159-168.
21. Anderson DA, Springer TA. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p 150, 95 glycoproteins. Annu Rev Med 1987;38:175-194.
22. Robertson RB, Wright TE, Mackler BF, Lenerts DM, Levy BM. Periodontal status of patients with abnormalities of the immune system. J Periodont Res 1978;13:37-45.
23. Kardachi BJR, Newcomb GM. A clinical study of gingival inflammation in renal transplant recipients taking immunosuppressive drugs. J Periodontol 1978;49:307-309.
24. Winkler JR, Grassi M, Murray PA. Clinical description and etiology of HIV-associated periodontal diseases. In: Robertson PB, Greenspan JS, eds. Oral Manifestation of AIDS. Littleton, MA: PSG Publishing Company; 1988:49-70.
25. Murayama Y, Nagai A, Okamura K, et al. Serum immunoglobulin G antibody to periodontal bacteria. Adv Dent Res 1988;2:339-345.
26. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 1998;3:51-61.